GLIS1 and ovarian carcinoma: In summary, we, for the first time, revealed that elevated GLIS1 expression in patient-derived CAFs of OSCs with metastatic potential, and that silencing GLIS1 in mCAFs reduced motility, adhesion, angiogenesis, and metastasis of ovarian cancer cells in vitro and in vivo.